United States · FDA National Drug Code directory
Clindamycin Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67296-2149_4637f034-6779-2599-e063-6394a90a7290
- Product NDC
- 67296-2149
- Form
- CAPSULE
- Composition / generic term
- Clindamycin Hydrochloride
- Labeler
- Redpharm Drug
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230310
- Source listing expiry
- 20261231
Source-listed ingredients
- CLINDAMYCIN HYDROCHLORIDE — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 21 CAPSULE in 1 BOTTLE (67296-2149-1) · 67296-2149-1
- 28 CAPSULE in 1 BOTTLE (67296-2149-2) · 67296-2149-2
- 30 CAPSULE in 1 BOTTLE (67296-2149-3) · 67296-2149-3
- 40 CAPSULE in 1 BOTTLE (67296-2149-4) · 67296-2149-4
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →